{"id":"W6958430703","doi":"10.6084/m9.figshare.29261647.v1","title":"Additional file 1 of Treatment with orforglipron, an oral glucagon like peptide-1 receptor agonist, is associated with improvements of CV risk biomarkers in participants with type 2 diabetes or obesity without diabetes","year":2025,"lang":"en","type":"article","venue":"Figshare","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"York University","funders":"","keywords":"Type 2 diabetes; Diabetes mellitus; Obesity; Glucagon-like peptide-1; Receptor; Glucagon-like peptide 1 receptor","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001526493,0.001234248,0.0018437,0.001667407,0.0008379798,0.001527558,0.001526648,0.001601718,0.8966431],"category_scores_gemma":[0.03762796,0.0006480752,0.002036674,0.002328049,0.0002933189,0.001599056,0.0008378405,0.0009888663,0.1285179],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009309093,"about_ca_system_score_gemma":0.001779768,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.006503207,"about_ca_topic_score_gemma":0.01198629,"domain_scores_codex":[0.9991438,0.0002091574,0.0001758331,0.0002097264,0.0001368908,0.0001245576],"domain_scores_gemma":[0.9691544,0.02481307,0.002260467,0.0010941,0.001963004,0.0007149248],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.003354726,0.0003282422,0.004475648,0.01179944,0.0003602804,0.00008998743,0.00006273681,0.0005041665,0.0001575745,0.001268959,0.957895,0.0197034],"study_design_scores_gemma":[0.09574771,0.002758952,0.1237245,0.01575656,0.002208611,0.001431888,0.0005321932,0.003815715,0.001385826,0.02390353,0.7282338,0.0005008075],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"dataset","genre_gemma":"other","genre_scores_codex":[0.0003441892,0.00007584079,0.0002132852,0.0001609494,0.00005221755,0.000150722,0.9976838,0.0001777875,0.001141224],"genre_scores_gemma":[0.02076715,0.000611893,0.007928833,0.002980943,0.0005479693,0.006425893,0.9396617,0.0009206246,0.02015508],"genre_candidate":"other","genre_consensus":null,"teacher_disagreement_score":0.8966431,"threshold_uncertainty_score":0.1474261,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02456597352879607,"score_gpt":0.2610832142826231,"score_spread":0.236517240753827,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}